3.5. Analysis.
Comparison 3 Trials not primarily intended at post‐stroke fatigue (individual results), Outcome 5 Karaiskos 2012 (duloxetine versus sertraline, continuous outcome.
Comparison 3 Trials not primarily intended at post‐stroke fatigue (individual results), Outcome 5 Karaiskos 2012 (duloxetine versus sertraline, continuous outcome.